158 related articles for article (PubMed ID: 36526610)
21. Drug-induced parkinsonism: Revisiting the epidemiology using the WHO pharmacovigilance database.
de Germay S; Montastruc F; Carvajal A; Lapeyre-Mestre M; Montastruc JL
Parkinsonism Relat Disord; 2020 Jan; 70():55-59. PubMed ID: 31865063
[TBL] [Abstract][Full Text] [Related]
22. Clozapine-induced myocarditis, a widely overlooked adverse reaction.
Ronaldson KJ; Fitzgerald PB; McNeil JJ
Acta Psychiatr Scand; 2015 Oct; 132(4):231-40. PubMed ID: 25865238
[TBL] [Abstract][Full Text] [Related]
23. Clozapine-related myocarditis and cardiomyopathy in an Australian metropolitan psychiatric service.
Reinders J; Parsonage W; Lange D; Potter JM; Plever S
Aust N Z J Psychiatry; 2004; 38(11-12):915-22. PubMed ID: 15555025
[TBL] [Abstract][Full Text] [Related]
24. Mapping endocrine toxicity spectrum of immune checkpoint inhibitors: a disproportionality analysis using the WHO adverse drug reaction database, VigiBase.
Bai X; Lin X; Zheng K; Chen X; Wu X; Huang Y; Zhuang Y
Endocrine; 2020 Sep; 69(3):670-681. PubMed ID: 32507965
[TBL] [Abstract][Full Text] [Related]
25. Myocarditis and cardiomyopathy associated with clozapine.
Kilian JG; Kerr K; Lawrence C; Celermajer DS
Lancet; 1999 Nov; 354(9193):1841-5. PubMed ID: 10584719
[TBL] [Abstract][Full Text] [Related]
26. Can Slow Personalized Titration Using C-Reactive Protein Monitoring Decrease the High Rates and Mortality of Clozapine-Associated Myocarditis Seen in Some Countries? A Call for Research.
de Leon J
J Clin Psychopharmacol; 2024 May-Jun 01; 44(3):212-219. PubMed ID: 38595145
[TBL] [Abstract][Full Text] [Related]
27. Adverse drug reactions of statins in children and adolescents: a descriptive analysis from VigiBase, the WHO global database of individual case safety reports.
Conte C; Rousseau V; Vert C; Montastruc F; Montastruc JL; Durrieu G; Olivier P
Fundam Clin Pharmacol; 2020 Aug; 34(4):518-520. PubMed ID: 32022302
[TBL] [Abstract][Full Text] [Related]
28. Clozapine-related neutropenia, myocarditis and cardiomyopathy adverse event reports in Australia 1993-2014.
Hollingworth SA; Winckel K; Saiepour N; Wheeler AJ; Myles N; Siskind D
Psychopharmacology (Berl); 2018 Jul; 235(7):1915-1921. PubMed ID: 29589067
[TBL] [Abstract][Full Text] [Related]
29. Reporting Patterns of Sialorrhea Comparing Users of Clozapine to Users of Other Antipsychotics: A Disproportionality Analysis Using VigiBase.
Man WH; Wilting I; Souverein P; Meyboom R; Egberts T; Heerdink ER
J Clin Psychopharmacol; 2020; 40(3):283-286. PubMed ID: 32332463
[TBL] [Abstract][Full Text] [Related]
30. High rates of myocarditis with clozapine in the Hunter region of Australia.
Tirupati S; Arachchi MK
Schizophr Res; 2024 Feb; 264():543-548. PubMed ID: 38330687
[TBL] [Abstract][Full Text] [Related]
31. A 12-month audit of clozapine associated myocarditis in a South Australian Local Health Network: The importance of screening and personalised titration.
Carswell O; Wilton LR; Nicholls K; Thomas V; Clark SR
Schizophr Res; 2024 Jun; 268():88-93. PubMed ID: 37722933
[TBL] [Abstract][Full Text] [Related]
32. Drug-induced liver injury in Switzerland: an analysis of drug-related hepatic disorders in the WHO pharmacovigilance database VigiBaseď from 2010 to 2020.
Ortland I; Mirjalili M; Kullak-Ublick GA; Peymani P
Swiss Med Wkly; 2021 May; 151():w20503. PubMed ID: 34000058
[TBL] [Abstract][Full Text] [Related]
33. Risk factors for clozapine-induced myocarditis and cardiomyopathy: A systematic review and meta-analysis.
Vickers M; Ramineni V; Malacova E; Eriksson L; McMahon K; Moudgil V; Scott J; Siskind D
Acta Psychiatr Scand; 2022 May; 145(5):442-455. PubMed ID: 35067911
[TBL] [Abstract][Full Text] [Related]
34. Rapid clozapine dose titration and concomitant sodium valproate increase the risk of myocarditis with clozapine: a case-control study.
Ronaldson KJ; Fitzgerald PB; Taylor AJ; Topliss DJ; Wolfe R; McNeil JJ
Schizophr Res; 2012 Nov; 141(2-3):173-8. PubMed ID: 23010488
[TBL] [Abstract][Full Text] [Related]
35. Incidence and risk factors for clozapine-induced myocarditis and cardiomyopathy at a regional mental health service in Australia.
Youssef DL; Narayanan P; Gill N
Australas Psychiatry; 2016 Apr; 24(2):176-80. PubMed ID: 26400457
[TBL] [Abstract][Full Text] [Related]
36. Clozapine and myocarditis: a case series from the New Zealand Intensive Medicines Monitoring Programme.
Hill GR; Harrison-Woolrych M
N Z Med J; 2008 Oct; 121(1283):68-75. PubMed ID: 18841187
[TBL] [Abstract][Full Text] [Related]
37. Clozapine-induced myocarditis: electronic health register analysis of incidence, timing, clinical markers and diagnostic accuracy.
Segev A; Iqbal E; McDonagh TA; Casetta C; Oloyede E; Piper S; Plymen CM; MacCabe JH
Br J Psychiatry; 2021 Dec; 219(6):644-651. PubMed ID: 35048875
[TBL] [Abstract][Full Text] [Related]
38. Systematic review and meta-analysis of rates of clozapine-associated myocarditis and cardiomyopathy.
Siskind D; Sidhu A; Cross J; Chua YT; Myles N; Cohen D; Kisely S
Aust N Z J Psychiatry; 2020 May; 54(5):467-481. PubMed ID: 31957459
[TBL] [Abstract][Full Text] [Related]
39. Atrial fibrillation in patients treated with intravenous zoledronic or pamidronic acid: a pharmacoepidemiological study.
Pijnenburg L; Salem JE; Lebrun-Vignes B; Sibilia J; Javier RM; Arnaud L
Eur J Endocrinol; 2021 Mar; 184(3):437-444. PubMed ID: 33449911
[TBL] [Abstract][Full Text] [Related]
40. Clozapine-induced myocarditis and patient outcomes after drug rechallenge following myocarditis: A systematic case review.
Richardson N; Greenway SC; Bousman CA
Psychiatry Res; 2021 Nov; 305():114247. PubMed ID: 34715441
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
